B. Winchester, Lysosomal metabolism of glycoproteins, Glycobiology, vol.15, issue.6, pp.1-15, 2005.
DOI : 10.1093/glycob/cwi041

J. Wraith, Lysosomal disorders, Paediatrics and Child Health, vol.21, issue.2, pp.75-83, 2002.
DOI : 10.1016/j.paed.2010.08.012

S. Ramsay, P. Meikle, J. Hopwood, and P. Clements, Profiling oligosaccharidurias by electrospray tandem mass spectrometry: Quantifying reducing oligosaccharides, Analytical Biochemistry, vol.345, issue.1, pp.30-46, 2005.
DOI : 10.1016/j.ab.2005.06.042

D. Wenger, S. Coppola, and S. Liu, Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases, Archives of Neurology, vol.60, issue.3, pp.322-328, 2003.
DOI : 10.1001/archneur.60.3.322

D. Marsden and H. Levy, Newborn Screening of Lysosomal Storage Disorders, Clinical Chemistry, vol.56, issue.7, pp.1071-1079, 2010.
DOI : 10.1373/clinchem.2009.141622

M. Jeyakumar, F. Norflus, C. Tifft, M. Cortina-borja, T. Butters et al., Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation, Blood, vol.97, issue.1, pp.327-329, 2001.
DOI : 10.1182/blood.V97.1.327

M. Laine, L. Ahtiainen, J. Rapola, J. Richter, and A. Jalanko, Bone marrow transplantation in young aspartylglucosaminuria mice: improved clearance of lysosomal storage in brain by using wild type as compared to heterozygote donors, Bone Marrow Transplantation, vol.34, issue.11, pp.1001-1003, 2004.
DOI : 10.1038/sj.bmt.1704665

E. Kelo, U. Dunder, and I. Mononen, Massive accumulation of Man2GlcNAc2-Asn in nonneuronal tissues of glycosylasparaginase-deficient mice and its removal by enzyme replacement therapy, Glycobiology, vol.15, issue.1, pp.79-85, 2005.
DOI : 10.1093/glycob/cwh145

J. Blanz, S. Stroobants, R. Lullmann-rauch, W. Morelle, M. Ludemann et al., Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in ??-mannosidosis mice, Human Molecular Genetics, vol.17, issue.22, pp.3437-3445, 2008.
DOI : 10.1093/hmg/ddn237

U. Dunder, P. Valtonen, and E. Kelo, Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria mice, Journal of Inherited Metabolic Disease, vol.144, issue.5, pp.611-617, 2010.
DOI : 10.1007/s10545-010-9158-7

M. Damme, S. Stroobants, S. Walkley, R. Lullmann-rauch, D. Hooge et al., Cerebellar alterations and gaitdefectsastherapeutic outcome measures for enzyme replacement therapy in alpha-mannosidosis

K. Higaki, L. Li, U. Bahrudin, S. Okuzawa, A. Takamuram et al., Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in ??-galactosidase deficiency, Human Mutation, vol.15, issue.7, pp.843-852, 2011.
DOI : 10.1002/humu.21516

A. Takamura, K. Higaki, H. Ninomiya, T. Takai, J. Matsuda et al., Lysosomal accumulation of Trk protein in brain of GM1-gangliosidosis mouse and its restoration by chemical chaperone, Journal of Neurochemistry, vol.45, issue.3, pp.399-406, 2011.
DOI : 10.1111/j.1471-4159.2011.07310.x

W. Krivit, C. Peters, and E. Shapiro, Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III, Current Opinion in Neurology, vol.12, issue.2, pp.167-176, 1999.
DOI : 10.1097/00019052-199904000-00007

M. Arvio, O. Sauna-aho, and M. Peippo, Bone marrow transplantation for aspartylglucosaminuria: Follow-up study of transplanted and non-transplanted patients, The Journal of Pediatrics, vol.138, issue.2, pp.288-290, 2001.
DOI : 10.1067/mpd.2001.110119

G. Malm, J. Mansson, J. Winiarski, M. Mosskin, and O. Ringden, Five-Year Follow-Up of Two Siblings with Aspartylglucosaminuria Undergoing Allogeneic Stem-Cell Transplantation from Unrelated Donors, Transplantation, vol.78, issue.3, pp.415-419, 2004.
DOI : 10.1097/00007890-200408150-00015

M. Miano, E. Lanino, R. Gatti, G. Morreale, P. Fondelli et al., Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation, Bone Marrow Transplantation, vol.27, issue.7, pp.747-751, 2001.
DOI : 10.1038/sj.bmt.1702994

M. Schiff, M. I. Bertrand, Y. Cochat, P. Guffon, and N. , Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: what does success mean?, Nephrology Dialysis Transplantation, vol.20, issue.11, pp.2563-2565, 2005.
DOI : 10.1093/ndt/gfi063

M. Mynarek, J. Tolar, M. Albert, M. Escolar, J. Boelens et al., Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients, Bone Marrow Transplantation, vol.80, issue.3, pp.352-359, 2012.
DOI : 10.1038/bmt.2011.99

A. Yesilipek, M. Akcan, G. Karasu, V. Uygun, A. Kupesiz et al., Successful unrelated bone marrow transplantation in two siblings with alpha-mannosidosis, Pediatric Transplantation, vol.32, issue.13, pp.779-782
DOI : 10.1111/j.1399-3046.2012.01763.x

J. Shield, J. Stone, and C. Steward, Bone marrow transplantation correcting ??-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosis, Journal of Inherited Metabolic Disease, vol.18, issue.5, pp.797-798, 2005.
DOI : 10.1007/s10545-005-0089-7

M. Masciullo, M. Santoro, A. Modoni, E. Ricci, J. Guitton et al., Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up, Journal of Inherited Metabolic Disease, vol.5, issue.S3, pp.33-355, 2010.
DOI : 10.1007/s10545-010-9186-3

J. Clarke, D. Mahuran, S. Sathe, E. Kolodny, B. Rigat et al., An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay???Sachs or Sandhoff variants), Molecular Genetics and Metabolism, vol.102, issue.1, pp.6-12, 2011.
DOI : 10.1016/j.ymgme.2010.09.004

M. Aguilar-moncayo, T. Takai, K. Higaki, T. Mena-barragan, Y. Hirano et al., Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis, Chemical Communications, vol.10, issue.52, pp.6514-6516, 2012.
DOI : 10.1039/c2cc32065g

R. Humbel and M. Collart, Oligosaccharides in urine of patients with glycoprotein storage diseases, Clinica Chimica Acta, vol.60, issue.2, pp.143-145, 1975.
DOI : 10.1016/0009-8981(75)90119-9

F. Hommes and M. Varghese, High-performance liquid chromatography of urinary oligosaccharides in the diagnosis of glycoprotein degradation disorders, Clinica Chimica Acta, vol.203, issue.2-3, pp.211-224, 1991.
DOI : 10.1016/0009-8981(91)90293-L

P. Meikle, M. Fietz, and J. Hopwood, Diagnosis of lysosomal storage disorders: current techniques and future directions, Expert Review of Molecular Diagnostics, vol.4, issue.5, pp.677-691, 2004.
DOI : 10.1586/14737159.4.5.677

G. Peelen, J. De-jong, and R. Wevers, HPLC analysis of oligosaccharides in urine from oligosaccharidosis patients, Clin Chem, vol.40, pp.914-921, 1994.

D. Chace and T. Kalas, A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing, Clinical Biochemistry, vol.38, issue.4, pp.296-309, 2005.
DOI : 10.1016/j.clinbiochem.2005.01.017

V. Faid, J. Michalski, and W. Morelle, A mass spectrometric strategy for profiling glycoproteinoses, Pompe disease, and sialic acid storage diseases, PROTEOMICS ??? CLINICAL APPLICATIONS, vol.17, issue.4, pp.528-542, 2008.
DOI : 10.1002/prca.200780097

P. Meikle, M. Fuller, and J. Hopwood, Mass spectrometry in the study of lysosomal storage disorders, Cell Mol Biol, vol.49, pp.769-777, 2003.

J. Sowell and T. Wood, Towards a selected reaction monitoring mass spectrometry fingerprint approach for the screening of oligosaccharidoses, Analytica Chimica Acta, vol.686, issue.1-2, pp.102-106, 2011.
DOI : 10.1016/j.aca.2010.11.047

E. Spina, L. Sturiale, D. Romeo, G. Impallomeni, D. Garozzo et al., New fragmentation mechanisms in matrix-assisted laser desorption/ionization time-of-flight/time-of-flight tandem mass spectrometry of carbohydrates, Rapid Communications in Mass Spectrometry, vol.18, issue.4, pp.392-398, 2004.
DOI : 10.1002/rcm.1350

B. Stahl, M. Steup, M. Karas, and F. Hillenkamp, Analysis of neutral oligosaccharides by matrix-assisted laser desorption ionization mass spectrometry, Analytical Chemistry, vol.63, issue.14, pp.1463-1466, 1991.
DOI : 10.1021/ac00014a022

D. Papac, A. Wong, and A. Jones, Analysis of Acidic Oligosaccharides and Glycopeptides by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, Analytical Chemistry, vol.68, issue.18, pp.3215-3223, 1996.
DOI : 10.1021/ac960324z

A. Pfenninger, M. Karas, B. Finke, B. Stahl, and G. Sawatzki, Matrix optimization for matrix-assisted laser desorption/ionization mass spectrometry of oligosaccharides from human milk, Journal of Mass Spectrometry, vol.28, issue.2, pp.98-104, 1999.
DOI : 10.1002/(SICI)1096-9888(199902)34:2<98::AID-JMS767>3.0.CO;2-N

D. Harvey, Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update covering the period 1999???2000, Mass Spectrometry Reviews, vol.16, issue.196, pp.595-662, 2000.
DOI : 10.1002/mas.20080

B. Domon and C. Costello, A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates, Glycoconjugate Journal, vol.4, issue.4, pp.397-409, 1988.
DOI : 10.1007/BF01049915

D. Harvey, Postsource decay fragmentation of N-linked carbohydrates from ovalbumin and related glycoproteins, Journal of the American Society for Mass Spectrometry, vol.256, issue.6, pp.572-577, 2000.
DOI : 10.1016/S1044-0305(00)00121-5

B. Xia, G. Asif, L. Arthur, M. Pervaiz, X. Li et al., Oligosaccharide Analysis in Urine by MALDI-TOF Mass Spectrometry for the Diagnosis of Lysosomal Storage Diseases, Clinical Chemistry, vol.59, issue.9, pp.591357-1368, 2013.
DOI : 10.1373/clinchem.2012.201053